Wanbangde Pharmaceutical Holding Group Co., Ltd. (SHE:002082)
China flag China · Delayed Price · Currency is CNY
16.21
-0.85 (-4.98%)
May 20, 2026, 12:05 PM CST

SHE:002082 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
575.01546.55158.73226.61467.62912.02
Short-Term Investments
--11.15---
Cash & Short-Term Investments
575.01546.55169.88226.61467.62912.02
Cash Growth
911.22%221.74%-25.04%-51.54%-48.73%58.84%
Accounts Receivable
798.67663.371,0381,1571,2631,157
Other Receivables
36.9721.1618.5758.6757.1520.54
Receivables
835.64684.531,0561,2161,3201,178
Inventory
214.31232.67213.86255.91283.15261.41
Prepaid Expenses
--5.583.314.464.13
Other Current Assets
211.81190.41357.81221.63125.34113.66
Total Current Assets
1,8371,6541,8031,9232,2012,469
Property, Plant & Equipment
1,5401,5591,5641,4951,2741,175
Long-Term Investments
122.53122.53112.0810.5212.3512.91
Goodwill
127.17128.86125.67125.46127.93194.79
Other Intangible Assets
576.33581.4461.79418.46430.97398.65
Long-Term Accounts Receivable
--14.0612.796.573.97
Long-Term Deferred Tax Assets
129.02137.03134.44113.6290.5454.23
Long-Term Deferred Charges
93.7893.963.0458.530.223.52
Other Long-Term Assets
128.16114.8248.91138.6944.4739.06
Total Assets
4,5544,3914,3274,2964,2184,371
Accounts Payable
355.92339.46247.36302.55231.18254.51
Accrued Expenses
20.3628.1867.3373.0863.7995.99
Short-Term Debt
652.73629.69855.17825.43677.96572.21
Current Portion of Long-Term Debt
179.98171.8254.1954.2737.2831.5
Current Portion of Leases
--3.242.650.550.54
Current Income Taxes Payable
60.9739.0618.1317.3424.6190.25
Current Unearned Revenue
35.635.2116.8214.3130.2833.21
Other Current Liabilities
183.78107.2954.0236.9871.61105.19
Total Current Liabilities
1,4891,3511,3161,3271,1371,283
Long-Term Debt
153.48172.710481.51135.2237
Long-Term Leases
10.5710.8511.6111.9913.431.22
Long-Term Unearned Revenue
94.0791.0592.1870.5468.0659.37
Long-Term Deferred Tax Liabilities
44.2545.3744.2140.8339.3633.5
Other Long-Term Liabilities
65.16112.992.685.916.4812.19
Total Liabilities
1,8571,7841,5711,5371,4001,627
Common Stock
611.69611.69616.69616.69618.22618.22
Additional Paid-In Capital
257.93257.93311.78311.78305.79305.79
Retained Earnings
1,7621,6591,8271,8201,8441,751
Treasury Stock
---59.99-59.99-59.99-50.96
Comprehensive Income & Other
-20.25-13.13-28.34-30.92-21-25.88
Total Common Equity
2,6122,5162,6672,6582,6872,598
Minority Interest
84.9991.6689.64101.28131.02146.33
Shareholders' Equity
2,6972,6082,7562,7592,8182,745
Total Liabilities & Equity
4,5544,3914,3274,2964,2184,371
Total Debt
996.76985.061,028975.84864.42842.48
Net Cash (Debt)
-421.75-438.51-858.34-749.23-396.869.54
Net Cash Per Share
-0.68-0.71-1.39-1.22-0.640.11
Filing Date Shares Outstanding
605.59611.69611.69611.69613.22614.08
Total Common Shares Outstanding
605.59611.69611.69611.69613.22614.08
Working Capital
347.43303.45487.05596.661,0641,185
Book Value Per Share
4.314.114.364.344.384.23
Tangible Book Value
1,9081,8062,0792,1142,1282,005
Tangible Book Value Per Share
3.152.953.403.463.473.26
Buildings
--893.08700.33577.02530.22
Machinery
--777.07703.7679.8668.65
Construction In Progress
--510.85611.33472.39380.88
Source: S&P Global Market Intelligence. Standard template. Financial Sources.